Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy
NCT03235167
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
CpG DNA
PROCEDURE:
transcatheter arterial chemoembolization
DRUG:
Placebo - Concentrate
Sponsor
Dalian University